Form 4: DURECT Corp Executive Sussman Reports Sale of 9,000 Shares Due to Administrative Error

DURECT Corp's Chief Medical Officer, Norman Sussman, reports the sale of 9,000 common stock shares due to an inadvertent administrative error.

Summary

• On December 10, 2021, Norman Sussman, Chief Medical Officer of DURECT Corporation, reported the sale of 9,000 shares of common stock.
• The sale was executed at a price of $1.055 per share.
• The transaction occurred due to an inadvertent administrative error by the account manager of Sussman's managed account, without his instruction or knowledge.
• The reported share numbers and price do not reflect the company's 10:1 reverse stock split.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the administrative error leading to an unauthorized stock sale and a late filing, raising concerns about internal controls.

Negatives

• The Form 4 filing is late due to an inadvertent administrative error.
• Shares were sold without the reporting person's knowledge.

Risks

• Administrative errors can lead to unintended stock sales by company executives.
• Late filings can raise concerns about compliance with SEC regulations.

Management Comments

• The sale reported herein was executed by the account manager for the benefit of the Reporting Person's managed account, without any instruction from or knowledge of the Reporting Person.

Industry Context

Form 4 filings are standard disclosures for corporate insiders, providing transparency into their transactions in the company's stock. Errors in these filings can raise concerns about internal controls.

Key Dates